For ER+ breast cancer, the burden of rare SNPs in gene FGFBP3 was nominally globally associated (p = 6×10−7) although follow-up using exact logistic regression gave a larger p-value (1.0×10−4). This evidence concerns the gene FGFBP3 and breast carcinoma.